Community Health Systems Inc. (NYSE:CYH) Q2 2021 Earnings Conference Call July 29, 2021 11:00 AM ET Company Participants Ross Comeaux - Vice President of Investor Relations Tim Hingtgen - CEO & Director Kevin Hammons - President & CFO Lynn Simon - President of Clinical Operations & Chief Medical Officer Conference Call Participants Brian Tanquilut - Jefferies Frank Morgan - RBC Capital Markets Josh Raskin - Nephron Research A.J. Rice - Crédit Suisse Ralph Giacobbe - Citi Steven Valiquette - Barclays Kevin F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ________ Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 13-3893 ...

Earnings Presentation — 1গ্ Quarter, 2021 Community alth Systems Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. All statements in this presentation other than statements of historical fact, including statements regarding projections, expected operat ...

Community Health Systems, Inc. (NYSE:CYH) Q1 2021 Earnings Conference Call April 29, 2021 11:00 AM ET Company Participants Ross Comeaux - Vice President and Investor Relations Tim Hingtgen - Chief Executive Officer Lynn Simon - President, Clinical Operations and Chief Medical Officer Kevin Hammons - President and Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Frank Morgan - RBC Capital Markets Jack Slevin - Jefferies Ralph Giacobbe - Citi Kevin Fischbeck - Bank of Americ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ________ Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. | --- | --- | --- | |------------------------------------------------- ...

J.P. Morgan Global High Yield & Leveraged Finance Conference March 2, 2021 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. All statements in this presentation other than statements of historical fact, including statements regarding projections, exp ...

Community Health Systems, Inc. (NYSE:CYH) Q4 2020 Earnings Conference Call February 18, 2021 11:00 AM ET Company Participants Ross Comeaux - Vice President of Investor Relations Tim Hingtgen - President & Chief Operating Officer Kevin Hammons - Executive Vice President & Chief Financial Officer Lynn Simon - President of Clinical Operations & Chief Medical Officer Conference Call Participants Frank Morgan - RBC Capital Markets Josh Raskin - Nephron Research Brian Tanquilut - Jefferies Ralph Giacobbe - Citi K ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 13-3893191 (State or other juris ...

39th Annual J.P. Morgan Healthcare Conference January 14, 2021 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. All statements in this presentation other than statements of historical fact, including statements regarding expected operating results, ...

Financial Data and Key Metrics Changes - Net revenue for the third quarter was approximately $3.1 billion, up 2.9% on a same-store year-over-year basis [17][49] - Adjusted EBITDA was $431 million, an increase of 11% compared to the previous year, with an adjusted EBITDA margin of 13.8%, up 180 basis points year-over-year [18][49] - Cash flows provided by operations were $393 million for the third quarter, compared to a negative $74 million during the same period in 2019 [51] Business Line Data and Key Metrics Changes - Admissions decreased by 6.2%, adjusted admissions were down 11.5%, and surgeries were down 5.8% [37] - Emergency room visits declined by 18.4%, primarily due to lower acuity patients not presenting [38] - Despite the decline in volumes, higher acuity and improved contract rates contributed to net revenue growth [37] Market Data and Key Metrics Changes - The company experienced a sequential improvement in admissions, surgeries, and ER business compared to the second quarter [15][36] - COVID-19 patient counts increased during the quarter, with approximately 8,000 confirmed cases in July, 6,000 in August, and 4,000 in September [25] - The company managed to maintain operations during significant hurricanes, which caused minor disruptions [33] Company Strategy and Development Direction - The company is focused on reshaping its portfolio into a stronger group of hospitals and healthcare systems, with divestitures nearing completion [19][41] - Investments in high-return capital expenditures are being accelerated to strengthen services and increase access points [20][44] - The company aims to leverage its strategic margin improvement program for long-term growth and margin expansion opportunities [43] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong strategies and a capable team to navigate challenges [12][47] - The company is continuously monitoring COVID-19 cases and is prepared to adjust operations as necessary [27][75] - Management highlighted the importance of maintaining safety protocols and effective patient care during the pandemic [30][31] Other Important Information - The company did not recognize any provider relief funds from the CARES Act during the quarter, with approximately $719 million received so far in 2020 [57] - The company has reduced its total debt and lowered its debt-to-EBITDA ratio through EBITDA growth and debt repayment [18][64] - The company has approximately $1.8 billion in cash on the balance sheet, with no outstanding borrowings [55][56] Q&A Session Summary Question: On margins and recovery pace - Management indicated that margin improvements are expected to be sustainable due to effective labor cost management and ongoing margin improvement initiatives [68][69] Question: COVID patient utilization and trends - Management noted that while there were surges in COVID cases, they did not require significant curtailment of elective procedures, and they are monitoring the situation closely [72][75] Question: Long-term population shifts and ER strategy - Management acknowledged potential population shifts but emphasized that their current markets remain stable, and they are focused on increasing market share [78][83] Question: Cash availability for deployment - Management highlighted uncertainties around COVID but expressed confidence in positive free cash flow moving forward, providing flexibility for future investments [88] Question: Characteristics of COVID inpatients - Approximately 45% of COVID cases were inpatient admissions, with a higher prevalence of Medicare Advantage patients among those hospitalized [90] Question: Labor trends and ER volumes - Management reported an increase in contract labor usage due to COVID surges but noted successful negotiations with staffing vendors to manage costs [95][98] Question: Prioritization of procedures - Management collaborates closely with medical staff to prioritize and reschedule procedures, focusing on both high-acuity and preventive care [104][110]